fasting vs glp 1 semaglutide and intermittent Your patient is losing weight fast on semaglutide. Here's the question almost FASTING and Ozempic for Max

Description

But Pfizer seems to have concluded that the toxicity question mark would damage its ability to compete in a relatively crowded space

Expert Consensus: American College of Physicians: GLP-1 receptor agonists should be considered for patients with obesity who have not achieved weight loss goals with lifestyle modifications. Endocrine Society: Semaglutide and tirzepatide represent significant advances in obesity pharmacotherapy and should be considered first-line options. Obesity Medicine Association: The dramatic efficacy of GLP-1 and dual agonist medications has fundamentally changed the treatment landscape for obesity. Real-World Effectiveness: Studies of patients using these medications outside clinical trials show: GLP-1s: Similar to clinical trial results (confirming real-world effectiveness) Older medications: Often less effective in real-world than trials (adherence issues) Patient satisfaction: Highest with GLP-1s Bottom Line: Which Works Best

These types of medications can help manage blood sugar levels, however early research is showing GLP-1 and anesthesia can create adverse complications for the patient

[DOI] [PubMed] [Google Scholar] 145.Trapp S., Brierley D.I

Breakthrough drugs such as semaglutide (Ozempic, Wegovy) and dulaglutide (Trulicity) are seeing strong uptake in both primary care and endocrinology practices